Age-Related Changes in the Natural Killer Cell Response to Seasonal Influenza Vaccination Are Not Influenced by a Synbiotic: a Randomised Controlled Trial

Agnieszka Przemska-Kosicka, Caroline E Childs, Catherine Maidens, Honglin Dong, Susan Todd, Margot A Gosney, Kieran Michael Tuohy, Parveen Yaqoob, Agnieszka Przemska-Kosicka, Caroline E Childs, Catherine Maidens, Honglin Dong, Susan Todd, Margot A Gosney, Kieran Michael Tuohy, Parveen Yaqoob

Abstract

Natural killer (NK) cells are an important component of the immune response to influenza infection, but are subject to alteration during aging, which may play a role in impaired response to infection and vaccination in older people. Enhancement of NK cell activity could, therefore, present a means to improve the immune response to vaccination in older subjects, and pre- and probiotics offer an opportunity to modulate antiviral defenses via alteration of the gut microbiota. This study investigated the effect of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486, combined with a prebiotic, gluco-oligosaccharide (B. longum + Gl-OS), on the NK cell response to seasonal influenza vaccination in young and older subjects in a double-blind, randomized controlled trial. There were significant effects of aging on NK cell phenotype, the most notable of which were an increase in CD56dim cells, mainly reflected in the CD16+ subset, a decrease in CD56bright cells, mainly reflected in the CD16- subset, and greater expression of the immunosenescence marker, CD57, on NK cell subsets. However, these changes only partially translated to differences in NK cell activity, observed as trends toward reduced NK cell activity in older subjects when analyzed on a per cell basis. Influenza vaccination increased the proportion of CD56bright cells and decreased the proportion of CD56dim cells, in young, but not older subjects. Although NK cell activity in response to vaccination was not significantly different between the young and older subjects, low post-vaccination NK cell activity was associated with poor seroconversion in only the older subjects. There was no influence of the synbiotic on NK cell phenotype or activity, either before or after influenza vaccination. In conclusion, aging is associated with marked alteration of the phenotype of the NK cell population and there was evidence of an impaired NK cell response to influenza vaccination in older subjects. The effects of aging on NK cell phenotype and activity could not be offset by B. longum + Gl-OS.

Clinical trial registration: www.ClinicalTrials.gov, identifier NCT01066377.

Keywords: aging; influenza; prebiotic; probiotic; vaccination.

Figures

Figure 1
Figure 1
CMV seropositivity is associated with an increase in CD57+CD3+CD56+NKT cells. Data are % of CD57+CD3+CD56+ NKT cells ± SEM for n = 40 young and n = 41 older subjects, ▫CMV−, ▪CMV+. Data were analyzed using independent samples t-test. *Denotes significant difference between CMV and CMV+ status in young (P < 0.001) and older subjects (P < 0.01).
Figure 2
Figure 2
Baseline natural killer cell activity. Data are mean ± SEM at week 0, for n = 54 subjects per group. Data were analyzed using independent samples t-test (2-tailed). P = 0.11 for E/T ratio 100:1, P = 0.54 for 50:1, P = 0.03 for 25:1, and P = 0.08 for 12.5:1.
Figure 3
Figure 3
Baseline natural killer cell activity on a per cell basis. Data are mean ± SEM at week 0, for n = 54 subjects per group. Data were analyzed using independent samples t-test (2-tailed). P = 0.02 for E/T ratio 100:1, P = 0.03 for 50:1, P = 0.038 for 25:1, and P = 0.116 for 12.5:1.

References

    1. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol (2014) 29:38–42.10.1016/j.coi.2014.03.008
    1. Pang IK, Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol (2011) 32:34–41.10.1016/j.it.2010.11.004
    1. Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol (2001) 124:392–7.10.1046/j.1365-2249.2001.01571.x
    1. Juárez-Reyes A, Noyola DE, Monsiváis-Urenda A, Alvarez-Quiroga C, González-Amaro R. Influenza virus infection but not H1N1 influenza virus immunization is associated with changes in peripheral blood NK cell subset levels. Clin Vaccine Immunol (2013) 20:1291–7.10.1128/CVI.00194-13
    1. Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev (2008) 129:223–30.10.1016/j.mad.2008.01.003
    1. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, Malarkannan S. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol (2009) 87:579–89.10.1038/icb.2009.60
    1. Du N, Zhou J, Lin X, Zhang Y, Yang X, Wang Y, et al. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol (2010) 84:7822–31.10.1128/JVI.00069-10
    1. Hall LJ, Clare S, Dougan G. NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. J Immunol (2010) 184:4327–37.10.4049/jimmunol.0903357
    1. Myśliwska J, Trzonkowski P, Szmit E, Brydak LB, Machała M, Myśliwski A. Immunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol (2004) 39:1447–58.10.1016/j.exger.2004.08.005
    1. Kutza J, Gross P, Kaye D, Murasko DM. Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diag Lab Immunol (1996) 3:105–8.
    1. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians [see comments]. Blood (1993) 82:2767–73.
    1. Yan J, Greer JM, Hull R, O’Sullivan JD, Henderson RD, Read SJ, et al. The effect of ageing on human lymphocyte subsets: comparison of males and females. Immun Ageing (2010) 7:1–10.10.1186/1742-4933-7-4
    1. Ginaldi L, De Martinis M, D’Ostilio A, Marini L, Loreto F, Modesti M, et al. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis. Am J Hematol (2001) 67:63–72.10.1002/ajh.1082
    1. Jentsch-Ullrich K, Koenigsmann M, Mohren M, Franke A. Lymphocyte subsets’ reference ranges in an age- and gender-balanced population of 100 healthy adults – a monocentric German study. Clin Immunol (2005) 116:192–7.10.1016/j.clim.2005.03.020
    1. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine (2000) 18:1613–20.10.1016/S0264-410X(99)00495-8
    1. Zhang YW, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology (2007) 121:258–65.10.1111/j.1365-2567.2007.02573.x
    1. Hazeldine J, Hampson P, Lord JM. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell (2012) 11:751–9.10.1111/j.1474-9726.2012.00839.x
    1. Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol (1999) 34:253–65.10.1016/S0531-5565(98)00076-X
    1. Chidrawar SM, Khan N, Chan YL, Nayak L, Moss PAH. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing (2006) 3:1–8.10.1186/1742-4933-3-10
    1. Le Garff-Tavernier M, Béziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell (2010) 9:527–35.10.1111/j.1474-9726.2010.00584.x
    1. Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro Ados S, Falcão RR, et al. Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol (2011) 72:319–29.10.1016/j.humimm.2011.01.009
    1. Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev (2005) 126:722–31.10.1016/j.mad.2005.01.004
    1. Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res (2013) 69:11–20.10.1016/j.phrs.2012.10.005
    1. Yasui H, Kiyoshima J, Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol (2004) 11:675–9.10.1128/CDLI.11.4.675-679.2004
    1. Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, et al. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol (2010) 50:597–602.10.1111/j.1472-765X.2010.02844.x
    1. Przemska-Kosicka A, Childs CE, Enani S, Maidens C, Dong H, Dayel IB, et al. Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence. Immun Ageing (2016) 13:6.10.1186/s12979-016-0061-4
    1. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev (1984) 28:47–55.10.1016/0047-6374(84)90152-0
    1. Hudon C, Fortin A, Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol (2005) 58:603–8.10.1016/j.jclinepi.2004.10.017
    1. Domogala A, Madrigal JA, Saudemont A. Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells. Cytotherapy (2016) 18:754–9.10.1016/j.jcyt.2016.02.008
    1. Enani S, Przemska-Kosicka A, Childs CE, Maidens C, Dong H, Conterno L, et al. Impact of ageing and a synbiotic on the immune response to seasonal influenza vaccination; a randomised controlled trial. Clin Nutr (2018) 37(2):443–51.10.1016/j.clnu.2017.01.011
    1. Derhovanessian E, Pawelec G. Vaccination in the elderly. Microb Biotechnol (2012) 5:226–32.10.1111/j.1751-7915.2011.00283.x
    1. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine (2006) 24:1159–69.10.1016/j.vaccine.2005.08.105
    1. Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev (2013) 12:1069–78.10.1016/j.arr.2013.04.003
    1. Campos C, Pera A, Sanchez-Correa B, Alonso C, Lopez-Fernandez I, Morgado S, et al. Effect of age and CMV on NK cell subpopulations. Exp Gerontol (2014) 54:130–7.10.1016/j.exger.2014.01.008
    1. Schapiro JM, Segev Y, Rannon L, Alkan M, Rager-Zisman B. Natural killer (NK) cell response after vaccination of volunteers with killed influenza vaccine. J Med Virol (1990) 30:196–200.10.1002/jmv.1890300310
    1. Jost S, Quillay H, Reardon J, Peterson E, Simmons RP, Parry BA, et al. Changes in cytokine levels and NK cell activation associated with influenza. PLoS One (2011) 6:1–9.10.1371/journal.pone.0025060
    1. Guo X, Chen Y, Li X, Kong H, Yang S, Ye B, et al. Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection. Virol J (2011) 8:215.10.1186/1743-422X-8-215
    1. Dong H, Rowland I, Yaqoob P. Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr (2012) 108:459–70.10.1017/S0007114511005824
    1. You J, Yaqoob P. Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486. FEMS Immunol Med Microbiol (2012) 66:353–62.10.1111/j.1574-695X.2012.01014.x
    1. Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, et al. Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr (2005) 94:452–81.10.1079/BJN20051469
    1. Morimoto K, Takeshita T, Nanno M, Tokudome S, Nakayama K. Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prev Med (2005) 40:589–94.10.1016/j.ypmed.2004.07.019
    1. Silvi S, Verdenelli MC, Orpianesi C, Cresci A. EU project Crownalife: functional foods, gut microflora and healthy ageing – isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Eng (2003) 56:195–200.10.1016/S0260-8774(02)00249-2
    1. Likotrafiti E, Manderson KS, Fava F, Tuohy KM, Gibson GR, Rastall RA. Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly adults. Microb Ecol Health Dis (2004) 16:105–112.10.1080/08910600410032376
    1. Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol (2001) 21:264–71.10.1023/A:1010979225018
    1. Moro-García MA, Alonso-Arias R, Baltadjieva M, Fernández Benítez C, Fernández Barrial MA, Díaz Ruisánchez E, et al. Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. Age (2013) 35:1311–26.10.1007/s11357-012-9434-6
    1. Olivares M, Díaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonollá J, Navas M, et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition (2007) 23:254–60.10.1016/j.nut.2007.01.004
    1. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr (1998) 52:899–907.10.1038/sj.ejcn.1600663
    1. Berman SH, Eichelsdoerfer P, Yim D, Elmer GW, Wenner CA. Daily ingestion of a nutritional probiotic supplement enhances innate immune function in healthy adults. Nutr Res (2006) 26:454–9.10.1016/j.nutres.2006.08.002
    1. Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr (2012) 107(6):876–84.10.1017/S000711451100420X
    1. Bunout D, Barrera G, Hirsch S, Gattas V, de la Maza MP, Haschke F, et al. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enteral Nutr (2004) 28:348–54.10.1177/0148607104028005348
    1. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr (2005) 24:481–91.10.1016/j.clnu.2005.02.006
    1. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine (2006) 24:6670–4.10.1016/j.vaccine.2006.05.048
    1. Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med (2007) 9:1–17.10.1017/S1462399407000221
    1. You J, Dong H, Mann ER, Knight SC, Yaqoob P. Ageing impairs the T cell response to dendritic cells. Immunobiology (2013).10.1016/j.imbio.2013.02.002
    1. Mandelboim M, Bromberg M, Sherbany H, Zucker I, Yaary K, Bassal R, et al. Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift. BMC Infect Dis (2014) 14:346.10.1186/1471-2334-14-346
    1. Hou J, Wang S, Jia M, Li D, Liu Y, Li Z, et al. A systems vaccinology approach reveals temporal transcriptomic changes of immune responses to the yellow fever 17D vaccine. J Immunol (2017) 199:1476–89.10.4049/jimmunol.1700083

Source: PubMed

3
Se inscrever